ArticleMolecular biomedicine2026
Aryl hydrocarbon receptor is involved in DNA damage repair after liver injury with diethylnitrosamine in mice.
Article in Molecular biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aryl hydrocarbon receptor (AhR) is a transcription factor traditionally involved in toxicological and carcinogenic cellular processes linked to xenobiotics. In recent decades, a new physiological role has emerged, in which AhR has been shown to be a key regulator of different processes such as the cell cycle, cell proliferation, apoptosis, pluripotency, and stemness. Recent studies have suggested a possible role for AhR in the DNA damage response (DDR) and repair mechanisms. To assess this point, in this work we used diethylnitrosamine (DEN) to induce liver injury and DNA damage in wild type (WT) and AhR knockout (KO) mice. We analysed the protein expression levels of several DDR (H2AX, 53BP1, and BRCA1) and cell proliferation (Ki67, AFP, and PCNA) markers. Therefore, we demonstrate that following DNA damage, the absence of AhR results in a shift towards apoptosis and compensatory proliferation mechanisms, accompanied by reduced repair fidelity of DNA damage compared with than in WT mice, compromising genomic stability. We also mapped the interactome profile of AhR, identifying new partners involved in both repair and proliferation processes. In conclusion, our results highlight the relevant role of AhR in cell proliferation and DNA repair processes, which can be key in different pathologies, such as cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.